A previous study showed an increased frequency of PD-1+TIM-3+CD4+ and PD-1+TIM-3+CD8+ T cells in the BM of ND-AML patients, but did not establish whether it has prognostic significance [27]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.